Polypoidal choroidal vasculopathy: Which Medications Cause It? (238 Reports Across 6 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Polypoidal choroidal vasculopathy has been reported as an adverse event with 6 different drugs in the FDA's FAERS database, with 238 total reports. The drugs most commonly associated with Polypoidal choroidal vasculopathy are RANIBIZUMAB, VERTEPORFIN, and AFLIBERCEPT.
238
Total Reports
6
Drugs Involved
0
Deaths
10
Hospitalizations
71.4 yrs
Average Patient Age
24.5% / 75.5%
Female / Male
Which Drugs Cause Polypoidal choroidal vasculopathy Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| RANIBIZUMAB | 153 | 1.0% | 0 | 6 | 2 |
| VERTEPORFIN | 128 | 17.0% | 0 | 5 | 2 |
| AFLIBERCEPT | 44 | 0.2% | 0 | 2 | 0 |
| BROLUCIZUMAB-DBLL | 10 | 0.4% | 0 | 0 | 0 |
| LUCENTIS | 6 | 0.9% | 0 | 0 | 0 |
| BEVACIZUMAB | 5 | 0.0% | 0 | 1 | 0 |